Key result
Biventricular defibrillation lowers mean defibrillation threshold by ~4 J compared with a standard system.
Why the study?
Standard implantable cardioverter-defibrillator leads in the right ventricle may have high defibrillation thresholds due to weak shock field intensity in the left ventricular myocardium, and biventricular defibrillation has not been tested in patients.
Does a biventricular defibrillation system reduce defibrillation thresholds compared to a standard system in patients receiving an ICD?
Does a biventricular defibrillation system reduce defibrillation thresholds compared to a standard system in patients receiving an ICD?
Biventricular defibrillation using a temporary LV lead is feasible and significantly reduces defibrillation energy requirements compared to standard RV systems.
Answers are grounded in this paper and cite their sources.
May lower DFTs during ICD testing in select patients; leaves open whether biventricular systems improve outcomes or warrant randomized trials.
Background Defibrillation thresholds (DFT) with standard implantable cardioverter-defibrillator leads in the right ventricle (RV) may be determined by weak shock field intensity in the myocardium of the left ventricle (LV). Adding a shocking electrode in a coronary vein on the middle of the LV free wall, thereby establishing biventricular defibrillation, substantially reduced defibrillation requirements in animals. We investigated the feasibility of this approach in 24 patients receiving an implantable cardioverter-defibrillator using a prototype over-the-wire temporary LV defibrillation lead. Methods and Results The LV lead was inserted through the coronary sinus, using a guide catheter and guidewire, into a posterior or lateral coronary vein whose location was determined by retrograde venography. Paired DFT testing compared a standard system (RV to superior vena cava plus can emulator [SVC+Can], 60% tilt biphasic shock) to a system including the LV lead. The biventricular system was tested with a dual-shock waveform (20% tilt monophasic shock from LV→SVC+Can, then 60% tilt biphasic shock from RV→SVC+Can). Twenty patients completed DFT testing. Venography and LV lead insertion time was 46±40 minutes. The biventricular system reduced mean DFT by 45% (8.9±1.1 J versus 4.9±0.5 J, P <0.001). Twelve patients (60%) had a standard system DFT ≥8 J, and the biventricular system gave a lower DFT in all patients. There were no adverse events related to the use of the LV lead, which was removed after testing. Conclusions Internal defibrillation using a transvenously inserted LV lead is feasible, produces significantly lower DFTs, and seems safe under the conditions tested. Biventricular defibrillation may be a useful option for reducing DFTs or could be added to an LV pacing lead for heart failure.
No takes yet. Share an insight, caveat, or question.
Butter et al. (2001) studied Patients receiving an implantable cardioverter-defibrillator (n=24). Biventricular defibrillation system including a left ventricular lead vs. Standard defibrillation system (RV to SVC plus can emulator) was evaluated on Mean defibrillation threshold (DFT) (p=<0.001). Biventricular defibrillation using a transvenous left ventricular lead reduced the mean defibrillation threshold compared to a standard system.
Synapse has enriched 10 related papers. Consider them for comparative context: